In NB, BDNF/TrkB expressions were found in tumors of patients with unfavorable prognosis [6], and BDNF/TrkB promoted NB cell survival and proliferation, and induced resistance to chemo-therapy in vitro and in vivo [25–27]. Here, NTRK2 is linked to neuroblastoma.